How Flexibility Can Deliver ATMP’s Potential
With the emergence of new medical treatments and therapies reaching the market, and thousands of new therapies also in preclinical and clinical stages, pharmaceutical manufacturing companies are looking to implement multi-model and flexible facilities. Jacobs’ Julie Vickers, Todd Rumsey, Peter Cramer and Francesca McBride discuss how to determine compatibility and congruence between primary and alternative modalities to deliver products with different manufacturing requirements and deliver transformative medicines to patients, faster.
View more